Projects per year
Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Melanoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Immunotherapy
Medicine & Life Sciences
Safety
Medicine & Life Sciences
Autophagy
Medicine & Life Sciences
Riluzole
Medicine & Life Sciences
Clinical Trials
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Janice Mehnert
- Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology - ASSOC PROF-TE
- Clinical Investigations and Precision Therapeutics Program, CINJ - FULL MEMBER
Person
Ann Silk
- Cancer Institute of New Jersey (CINJ), Melanoma & Soft Tissue Oncology - ASST PROF-CLIN
- Brain Health Institute - MEMBER
Person
Projects 1997 2024
Promoting Bim-driven apoptosis through MAPK inhibition: A therapeutic strategy in advanced melanoma
Mehnert, J. & Sullivan, R.
12/8/15 → 11/30/20
Project: Research project
Mitogen-Activated Protein Kinase Kinases
Melanoma
Apoptosis
Therapeutics
Disease-Free Survival
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
Mehnert, J., DiPaola, R. S. & Glenn, L.
3/19/14 → 2/29/20
Project: Research project
Neoplasms
Clinical Trials
Therapeutics
Systems Biology
Pharmacogenetics
CANCER CENTER SUPPORT GRANT
Kane, M., Zong, W., Mehnert, J., Manne, S., Delnevo, C., Shen, Z., Ganesan, S., Foran, D., Liu, C., Laskin, D., Shih, W., Aisner, J., Lattime, E., Haffty, B., Bertino, J., August, D., Goodin, S., Goodin, S., August, D., Laskin, D., Shih, W., Rabinowitz, J., Zheng, S., Sant'Angelo, D. B., Saunders, T., Tanzer, L. L., Gallo, J., Leibowitz, M., Chin, K. V., Ravikumar, T., Hait, W., Dipaola, R., Libutti, S. K., Kinzy, T. G., Spaulding, H., Amenta, P., Denicola, G., Shen, M. M., Kinzy, T. G., Notterman, D., Amenta, P. S., Rubin, E. H. & Cunningham, R. S.
3/1/97 → 2/29/24
Project: Research project
Neoplasms
Research
Financial Management
Organized Financing
New Brunswick
Research Output 2002 2020
Association of Rising Cost and Use of Oral Anticancer Drugs with Medicare Part D Spending from 2013 Through 2017
Seiger, K., Mostaghimi, A., Silk, A. W., Schmults, C. D. & Ruiz, E. S., Jan 2020, In : JAMA Oncology. 6, 1, p. 154-156 3 p.Research output: Contribution to journal › Letter
Medicare Part D
Costs and Cost Analysis
Pharmaceutical Preparations
5
Citations
(Scopus)
Avelumab in patients with previously treated metastatic melanoma: Phase 1b results from the JAVELIN Solid Tumor trial
Keilholz, U., Mehnert, J. M., Bauer, S., Bourgeois, H., Patel, M. R., Gravenor, D., Nemunaitis, J. J., Taylor, M. H., Wyrwicz, L., Lee, K. W., Kasturi, V., Chin, K., Von Heydebreck, A. & Gulley, J. L., Jan 16 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 12.Research output: Contribution to journal › Article
Melanoma
Neoplasms
Therapeutics
Disease-Free Survival
Survival
2
Citations
(Scopus)
Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma
Andtbacka, R. H. I., Amatruda, T., Nemunaitis, J., Zager, J. S., Walker, J., Chesney, J. A., Liu, K., Hsu, C. P., Pickett, C. A. & Mehnert, J. M., Sep 2019, In : EBioMedicine. 47, p. 89-97 9 p.Research output: Contribution to journal › Article
Open Access
Oncolytic Viruses
Viruses
Melanoma
Occlusive Dressings
Blood